chrisvoncsefalvay/vaers-outcomes huggingface dataset:
got sick everytime; Initial information received on 06-Dec-2020 regarding an unsolicited valid non-serious social media case received from a non-healthcare professional (patient).   This case involved an unknown age of female patient who got sick everytime (Illness) after receiving INFLUENZA VACCINE.  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications were unknown.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number, expiry date and other dosing details were not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, unknown latency, the patient got sick everytime she got the flu shot. Every time no exaggeration (illness).  No relevant laboratory details were provided.  It was not reported if the patient received a corrective treatment.  Outcome of the events were reported as unknown. It was not reported if the patient received a corrective treatment.  There will be no information available on the batch number for this case.
Initial report was received from a consumer on 16 May 2013. A 19-year-old female patient had received a dose two intradermal injection of MENACTRA, lot number U4593AB, instead of TUBERSOL. On 14 May 2013 (also reported as two days later), the patient came in to have the test read and the arm was swollen with cellulitis. Treatment was BACTRIM twice daily (BID) and to apply cold packs. The patient had no illness at the time of vaccination and no past medical history. Outcome was not recovered. Documents held by sender: None.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 035C21A and 027L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Jan-2021 at 3:04 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 03-Nov-2021 at 1:51 PM, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. In 2021, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient age was reported age 72.23 and 71.41, during initial and later dose respectively. No concomitant medication was reported by reporter. Batch number 035C21A underwent temperature excursion on 03-Nov-2021 with temperature 35 degrees Fahrenheit at 10:00 AM . This vial was moved to fridge on 05-Oct-2021 and beyond use date for the vial was reported as 05-Nov-2021. Product moved to clinic on 16-JUN-2022. Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. It was reported that each time a vial was put into a cooler, sometimes there was a period of time of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34 or 35 degree Fahrenheit. Temperature recordings were taken by using a temperature monitor at every hour. The vial was not in a frozen state at the time of vaccine administration. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature. No treatment information was provided.
Rash around the area of the vaccine; This spontaneous case was reported by an attorney and describes the occurrence of VACCINATION SITE RASH (Rash around the area of the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE RASH (Rash around the area of the vaccine). At the time of the report, VACCINATION SITE RASH (Rash around the area of the vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details not reported by the reporter.
The next day I had severe diarrhea and extreme gas.  It has improved slightly since then but has continued. I went to the Dr. and have had a stool culture done which was negative and a colonoscopy which was also negative.
Severe nausea, cognitive impaired, fever, chills, night sweats, memory loss,  dizziness
One week after developed rash and hard lump very sore in morning.Taking ibuprofen in morning only
Extreme pain and very high fevers for 20 hours; it felt as if all of my bones were broken.  Eztraordonary thirst, inability to stay awake (all day 8/21).  On 8/22, I now have swollen lymph nodes, increased swelling at injection site, and extreme bloating of my abdomen
vaccine site is unusually swollen circumfrance is larger than a golf ball slightly smaller than a baseball and significantly bruised. The swelling and bruising has gradually increased over the last  29 or so hours. I have limited mobility moving my arm up and down. Mild fever 101.2 around 11p 4.7, currently at 99.8 @ 441p CST.  approx 6/7-ish hours after shot including hot and cold sweats fatigue and body aches.
Severe vomiting throughout entire first night after receiving shot. He also had flu like symptoms which were anticipated but he vomited 6 times over night.
Left arm around the injection site became very painful, red, swollen, and warm to the touch.  This has continued for 3 days, with itching beginning on the 3rd day.
After 3 vaccinations. Pt looks delirious and then fainted. I caught pt from falling of the chair. She was out for at least 10-15 seconds. I called for help and the person called for 911.  I (pharmacist) waited till ambulance to come. She was a little out of it. She takes Blood pressure medication. She told me she was afraid of needles after waking up, She was dizziness/nauseous as well. She doesn't give blood anymore before she faints. Ambulance came and pulse was low 45. They took her to the hospital.
pt devel screaming & crying that started 1hr p/vax & lasted 10-12hrs;thighs red & swollen <24hrs;slept afterwards; OK in AM;
Extremely heavy period after the first shot. Worst one I've ever had. Strange dreams at night. After the second shot I had a rapid heart beat and slow breathing. Major headache about 3 hrs later.
Starting in afternoon 4/11/07 noted quarter sized redness and swelling at injection site of back of (L) arm then 4/12 progressed to "baseball" size swelling/redness with warmth to touch. Denies generalized fever or other c/o
Major headache (migraine), Nausea, Eyes hurt.  6/6/08 Reviewed ER medical records for 5/28/2008 FINAL DX: Records reveal patient experienced nausea, chills & HA which he rated as 8.5-9 since 5/18. LP done.   7/4/08 Reviewed neuro consultant medical records of 5/30/08 FINAL DX: mild aseptic meningitis, likely secondary to smallpox vaccine Records reveal patient experienced intermittent nausea s/p vaccination for approx 2 weeks.  Then developed severe HA w/o relief until seen in ER & given parenteral pain meds.
sore arm; Initial information regarding an unsolicited valid non-serious social media case received from a non-healthcare professional (consumer) via social media on 29-Oct-2020.  This case involved a patient of an unknown age and gender who experienced sore arm (Pain in extremity), after receiving INFLUENZA VACCINE.  Medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by an unknown manufacturer (lot number and expiry date were not reported) via an unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date (unknown latency), the patient developed sore arm (Pain in extremity) for couple of days.   No relevant laboratory details were provided.    It was not reported if the patient received a corrective treatment.  Outcome of the event was unknown.  There will be no information available on the batch number for this case.
During public flu clinic, client requested flu vaccine. Client spoke a different language. Student nurse and instructor screened client using interpreter. Client requested flu mist. Client did not state she was pregnant. Student nurse did not specifically ask if client was pregnant during screening. No adverse event noted. Client physician notified.
UNABLE TO DO ANY ACTIVITY; BARELY EVEN WALK WITHOUT CHEST PAIN/PAIN; WAKE UP IN THE MIDDLE OF THE NIGHT WITH A RACING HEART; BARELY EVEN WALK; This spontaneous report received from a patient concerned a 35 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient was healthy and exercised 3 to 4 times per week before vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on OCT-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced unable to do any activity, barely even walk without chest pain/pain, wake up in the middle of the night with a racing heart, and barely even walk. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from barely even walk without chest pain/pain, and barely even walk, and the outcome of unable to do any activity and wake up in the middle of the night with a racing heart was not reported. This report was non-serious.
Brief 1-2 second episodes of vertigo once or twice daily since day of vaccination, reported on 6/10/2021. Of note, patient had one such episode of vertigo one week prior to first vaccination on or about 5/13/2021, so not entirely clear that this was new symptom after vaccine, but frequency did increase. No other associated cardiac or neurologic symptoms.
Headache, Myalgia,  chills Narrative:  Headache, myalgia, chills.
Headache, Myalgia, chills Narrative:  Employee reported moderate headaches 01/26/21, moderate injection site pain 01/26/21, severe chills 01/26/21. Resulted in unable to work one day following vaccination 01/26/21.
Patient complained of dizziness and presented with substernal chest pain and mild shortness of breath within 15-20 minutes after receiving COVID-19 vaccine. History of hypertension and non-compliance with antihypertensive medications. Relative reports patient also with possible history of stroke with no anticoagulation. Patient hypertensive initially with Systolic in 180s and diastolic in the 80s, upon onset of symptoms. Chest pain minimized within 10 minutes after blood pressure came down to the systolic level in the 170s. Ground ambulance called to transport to Emergency Department, but patient declined ambulance transport and was taken to ED by car with son-in -law.
sleepy for one day.; This is a spontaneous report from a non-contactable consumer. A female patient of unknown age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. On an unknown date in 2021, the patient experienced sleepy for one day. No therapeutic measures were taken as a result of the reported event. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the event sleepy for one day was recovered on an unknown date in 2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Felt symptoms within a few hours after vaccine. Had bodyaches, headache, felt like he had a fever which continued through evening. Still felt poorly the next morning(10/31). Felt dizzy in shower, got out and had syncopal episode hitting head on floor. Required transport to ER, cardiac workup, sutures and stated orbital Fx. States symptoms were gone by evening of 10/31.
Pain & redness to R/arm. Treatment: Warm compresses; Keflex 250mg; Benadryl 25mg for itching.
This case was reported by a medical representative and described the occurrence of fatigue in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced fatigue. On an unknown date, the outcome of the fatigue was unknown. It was unknown if the reporter considered the fatigue to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The patient was reluctant to get her second dose of SHINGRIX due to the reaction. The reporter was unable to obtain additional details of the event or demographics of the patient.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, medical history, any known allergies or reactions or concomitant medications. On an unknown date, the patients were vaccinated with multiple doses of improperly stored ROTATEQ lot # M038846 with expiration date of 26-APR-2018, orally, for prophylaxis (dose was not reported). Administered doses of vaccines experienced the temperature excursion of 32.1 degrees Fahrenheit (°F) for 12 hours. There were not previous excursions or data logger involved.  No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1705USA001619.
The day after my second dose I started having lower back pain and pain in my thighs.  As days pass the pain has only intensified. I've had tingling, numbness, extreme sensitivity and a deep dull pain in my thighs. I use lidocaine patches for my back. But the pain in my legs does not go away. It intensifies in the evenings and at night. I have not been able to sleep since the pain started.
Covid 19 positive in two tests, aches, tight chest, fatigue, flue like symptoms but very little temp elevation.    Note:  In addition to info in Item 17  2nd innoculation Pfizer EM9810  and booster Pfizer FF2593  Treatment: monoclonal antibodies IV on 01/17/2022.   Rapid recovery save lingering symptoms, notably fatigue, some aches, productive cough.  One month later, fatigue is the most notable remaining symptom.
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients administered Moderna vaccine while temperature excursion assessment was ongoing; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients administered Moderna vaccine while temperature excursion assessment was ongoing) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients administered Moderna vaccine while temperature excursion assessment was ongoing). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients administered Moderna vaccine while temperature excursion assessment was ongoing) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications information was reported.  It was reported that there have been no power outages that would have impacted the Moderna vaccine. However, reporter reiterated that because her facility was unable to download the digital data logger, they would need to treat this issue as a temperature excursion. The data logger that caller was unable to download for the months of DEC2021, JAN2022, and FEB2022. Reporter said that they are filling out a temperature excursion assessment with the State at this time and she was calling in to report the same to Moderna. Reporter confirmed that patients have been administered doses while the temperature excursion assessment has been ongoing.  It was reported that no adverse reactions were reported by any patients.
Pain, redness and hardness at injection site for 3 plus days, itching all over the body for 3 plus days. Patient treating itching with BENADRYL.
Red spot 3 inches x 2 inches, occasional itching, sore to touch, warm to touch -  so far lasting 9 days.
very sever adrenalin rushing thru my body; patient received other vaccine on same date; patient received other vaccine on same date; This is a spontaneous report from a contactable consumer (patient). A 69-years-old female non-pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: 0938749-02170/Batch number was not reported) via an unspecified route of administration, administered in arm left on 24Sep2021 at 14:00 (at the age of 69-year-old) as dose 1, single and bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: 77867498/Batch number was not reported) via an unspecified route of administration, administered in arm left on 24Sep2021 (at the age of 69-year-old) as dose 2, single; both for COVID-19 immunisation at Pharmacy. Medical history included Cancer multipul myeloma, breast cancer, heavy metal, A flutter, thyroid, art condition a/flutter, thyroid under active and heart a flutter. Concomitant medications included atenolol at a dose of 50 mg; letrozole at 2.5; lenalidomide (REVLIMID) at a dose of 10 mg and thymg, all taken for an unspecified indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient allergies were reported as many. On 24Sep2021, the patient received other vaccine on same date and at 14:30 the patient experienced very sever adrenalin rushing thru my body. Patient did not receive treatment for the events. Outcome of the event very sever adrenalin rushing thru my body was recovering.  Follow-up attempts are completed. No further information is expected.
Redness persisted for 3 weeks; Swelling persisted for 3 weeks; Tender; Warm; This case was reported by a pharmacist via call center representative and described the occurrence of erythema in a 54-year-old female patient who received Herpes zoster (Shingrix) (batch number 3FJ59, expiry date 27th November 2021) for prophylaxis.   On 10th September 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 4 months after receiving Shingrix, the patient experienced erythema, swelling, tenderness and feeling of warmth. On an unknown date, the outcome of the erythema, swelling, tenderness and feeling of warmth were recovered/resolved.   It was unknown if the reporter considered the erythema, swelling, tenderness and feeling of warmth to be related to Shingrix.  Additional details were provided as follows: The patient experienced redness, swelling, tender and warm that persisted for 3 weeks. The reporter did not consent to follow-up.
lips felt swollen, throat tightness. Evaluated by EMS-Refusal to transport.
AT 1130, THE FLU VACCINE WAS GIVEN. PATIENT C/O PAIN AT INJECTION SITE. 1230-1300, PATIENT REPORTS PAIN RADIATING UP TO SHOULDER AND NECK AND DOWN RIGHT ARM TO HAND, WITH SWELLING NOTED IN RIGHT HAND 3RD AND 4TH KNUCKLES. REDNESS AND WARMTH AT INJECTION SITE. DEXAMETHASONE 10MG/1ML GIVEN IM TO R DELTOID. DEPO-MEDROL 40MG/1ML IM GIVEN R DELTOID. NO IMPROVEMENT. PATIENT C/O SOB AT 1320. 20 GAUGE IV TO LEFT AC. DEXAMETHASONE 10MG/1ML IVPD AND BENADRYL 50MG IVPB ADMINISTERED. SYMPTOMS SUBSIDED.
Temp of 100.2 left arm ache from vaccine (localized to injected limb) Narrative:
Tdap shot hurt immediately when pt. received it. Flu vaccination did not hurt. Pt put ice and heat on it. Pt. has tried NSAIDs w/ very slight relief. Pt. is having sleepless nights. Pain running down arm to hands on both sides. Lifting arms hurts. Pain specialist seen 2 weeks after and pt has another apt. to see pain specialist today - 10/11/12.
Case number PHEH2016US029264, is an initial spontaneous report received from a nurse on 07 Nov 2016. This report refers to a 28 years old female patient. Past medical history and concomitant medication were not reported. The patient was vaccinated with FLUCELAX Quadrivalent (batch number: not reported) at a dose of 0.5 ml intramuscularly following temperature  excursion at 52 Fahrenheit for 1 hour on 18 Oct 2016. Second temperature excursion occurred on 23 Oct 2016, dropped low 06 times to 34 Fahrenheit and lasted 30 minutes each time. Third temperature excursion occurred on 02 Nov 2016, down to 32.2 Fahrenheit three time over the course of 12 hours. Vaccine had been administered. It was unknown if the vaccine was frozen. Nurse did not know which lot given to which patient. No adverse event was reported following this administration error.